Institut Gustave-Roussy
Research / Science organisation
Location:
Villejuif,
France (FR)
ISNI: 0000000122849388
ROR: https://ror.org/0321g0743
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report (2016)
Kager L, Whelan J, Dirksen U, Hassan B, Anninga J, Bennister L, Bovee JVMG, et al.
Journal article
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group (2016)
Denkert C, Wienert S, Poterie A, Loibl S, Budczies J, Badve S, Bago-Horvath Z, et al.
Journal article
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project+ (2015)
Kramar A, Negrier S, Sylvester R, Joniau S, Mulders P, Powles T, Bex A, et al.
Journal article
Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group (2015)
Kasper B, Baumgarten C, Bonvalot S, Haas R, Haller F, Hohenberger P, Moreau G, et al.
Journal article
Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe (2015)
Boelling T, Braun-Munzinger G, Burdach S, Calaminus G, Craft A, Delattre O, Deley MCL, et al.
Journal article
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death (2015)
Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, et al.
Journal article
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer (2014)
Loibl S, Von Minckwitz G, Schneeweiss A, Paepke S, Lehmann A, Rezai M, Zahm DM, et al.
Journal article